DOCS vs LH
DOCS: Doximity operates the leading professional network for U.S. physicians, providing a digital platform that streamlines clinical workflows and connects healthcare providers with commercial and career opportunities. LH: A global diagnostics and drug development laboratory leader that performs 750+ million clinical tests annually and supports 85% of new FDA-approved drugs through comprehensive testing capabilities.
Side-by-side fundamentals
| Metric | DOCS | LH | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $20.99 | $301.17 | |
| Market cap as of 2026-07-29 | $3.9B | $25.8B | |
| P/E as of 2026-07-29 | 21.39 | 26.69 | DOCS lower |
| PEG as of 2026-07-29 | n/a | 2.76 | |
| Net margin as of 2026-07-29 | +30.4% | +6.7% | DOCS higher |
| Gross margin as of 2026-07-29 | +89.1% | +28.8% | DOCS higher |
| Operating margin as of 2026-07-29 | +33.3% | +10.2% | DOCS higher |
| ROE as of 2026-07-29 | +19.4% | +10.9% | DOCS higher |
| ROA as of 2026-07-29 | +16.5% | +5.1% | DOCS higher |
| Debt / equity as of 2026-07-29 | 0.00 | 0.73 | DOCS lower |
| Revenue growth (YoY) as of 2026-07-29 | +13.1% | +7.3% | DOCS higher |
| Revenue CAGR (3y) SEC XBRL | +15.5% | +5.6% | DOCS higher |
| Dividend yield as of 2026-07-29 | n/a | +1.0% | |
| Dividend streak (yrs) SEC XBRL | n/a | 4 | |
| Beta as of 2026-07-29 | 1.21 | 0.86 | |
| 1-year return as of 2026-07-27 close | -65.5% | +13.7% | LH higher |
Fundamentals: Finnhub, as of 2026-07-29. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.